NeuBase Therapeutics Inc Accelerating the Genetic Revolution with a New Class of Synthetic Medicines Transcript
Good morning, everyone or good evening, depending on where you guys are coming in from today. This is John Heerdink. I'm the Founder and Managing Member of Tribe Public. And I'm excited again today to have Dietrich Stephan, Founder, CEO of NeuBase Therapeutics. NeuBase trades on the Nasdaq, symbol NBSE.
I'm proud to be an investor in the company, been in since the company went public as I participated in around and I've added an investment sense. Again, thank you all from the Tribe that come in from around the world, and I look forward to hearing from you after this call.(Conference Instructions)
But I'm going to allow Dietrich to introduce himself again, for those of you that haven't met him. And at the same time, please do send your questions. He's going to do about a 15-, 20-, 30-minute, depending on the presentation, how quickly it goes. And he's had some exciting data that he's going to share with us that came out at the end of last week, and I think will accelerate his company and platform as he moves forward.
So Dietrich, thanks again
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
